Lacerta Therapeutics Competitors and Similar CompaniesClear all
Lacerta Therapeutics's competitors and similar companies include Taysha Gene Therapies, StrideBio and Dyne Therapeutics.
 StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases. |  Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2020 | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Alachua, US HQ Alachua, US | Locations Dallas, US HQ | Locations US HQ | Locations Waltham, US HQ |
Employees | Employees 147% decrease | Employees 5220% decrease | Employees 7 | Employees 1451% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 411.9 m | Valuation ($) N/A | Valuation ($) 3.5 b |
Financial | ||||
Net income | Net income N/A | Net income ($111.6m) (FY, 2023) | Net income N/A | Net income ($235.9m) (FY, 2023) |
Funding | ||||
Latest funding round | Latest funding round $ 30m (about 6 years ago) | Latest funding round N/A | Latest funding round $ 81.5m (over 3 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 30m | Total funding raised $ 125m | Total funding raised $ 97.2m | Total funding raised $ 165m |
For sources of this data, please see the company profile
View Company Profiles
Taysha Gene Therapies
HQ
Dallas, US
Employees
52↓ 20% decrease
Taysha Gene Therapies is a biotechnology company that develops therapies.
View companyStrideBio
HQ
US
Employees
7
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
View companyDyne Therapeutics
HQ
Waltham, US
Employees
145↓ 1% decrease
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View company